Abstract
Bone marrow from each of two inbred mouse strains, C57BL/6J and DBA/2J, was highly enriched for stem cells using flow cytometry and was divided into two stem cell subpopulations using the mitochondrial dye rhodamine 123 (Rh-123). The Rh-123lo population was determined to be more primitive than Rh-123hi based on the expression of stem cell markers such as the c-kit protooncogene (stem cell factor receptor) and the Ly-6A/E stem cell antigen (Sca-1) as well as the lack of in vitro colony-forming ability. Compared to DBA/2J mice, marrow from the C57BL/6J strain consistently showed a higher proportion of "very primitive" (Rh-123lo) cells, suggesting that the sizes of functionally distinct stem cell subpopulations are maintained under precise genetic control. Marrow from both strains exposed to the cytotoxic drug 5-fluorouracil showed a dramatic increase in the proportion of Rh-123lo cells within 2 days as repopulation began. Marrow subpopulations returned to pretreatment proportions by the eighth day in DBA/2J mice but not until 14 days in C57BL/6J mice. This intrinsic difference in 5-fluorouracil recovery time was attributed to an increase rate of stem cell cycling in DBA/2J relative to C57BL/6J mice. When stem cell factor was injected into a C57BL/6J<-->DBA/2J allophenic mouse, blood cell chimerism shifted markedly but transiently toward the DBA/2J genotype, suggesting that the DBA/2J target population, because of an inherent kinetic advantage, was able to respond faster to the cytokine. A model is proposed that is based on these and our earlier observations to explain this strain-specific stem cell behavior and offer new insights into the genetic control of stem cell cycling and population dynamics.
Full text
PDF




Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Chaudhary P. M., Roninson I. B. Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells. Cell. 1991 Jul 12;66(1):85–94. doi: 10.1016/0092-8674(91)90141-k. [DOI] [PubMed] [Google Scholar]
- Flanagan J. G., Leder P. The kit ligand: a cell surface molecule altered in steel mutant fibroblasts. Cell. 1990 Oct 5;63(1):185–194. doi: 10.1016/0092-8674(90)90299-t. [DOI] [PubMed] [Google Scholar]
- Ford J. M., Hait W. N. Pharmacology of drugs that alter multidrug resistance in cancer. Pharmacol Rev. 1990 Sep;42(3):155–199. [PubMed] [Google Scholar]
- Heimfeld S., Hudak S., Weissman I., Rennick D. The in vitro response of phenotypically defined mouse stem cells and myeloerythroid progenitors to single or multiple growth factors. Proc Natl Acad Sci U S A. 1991 Nov 1;88(21):9902–9906. doi: 10.1073/pnas.88.21.9902. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ikuta K., Weissman I. L. Evidence that hematopoietic stem cells express mouse c-kit but do not depend on steel factor for their generation. Proc Natl Acad Sci U S A. 1992 Feb 15;89(4):1502–1506. doi: 10.1073/pnas.89.4.1502. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Iscove N. Haematopoiesis. Searching for stem cells. Nature. 1990 Sep 13;347(6289):126–127. doi: 10.1038/347126a0. [DOI] [PubMed] [Google Scholar]
- Jones R. J., Wagner J. E., Celano P., Zicha M. S., Sharkis S. J. Separation of pluripotent haematopoietic stem cells from spleen colony-forming cells. Nature. 1990 Sep 13;347(6289):188–189. doi: 10.1038/347188a0. [DOI] [PubMed] [Google Scholar]
- Jordan C. T., Lemischka I. R. Clonal and systemic analysis of long-term hematopoiesis in the mouse. Genes Dev. 1990 Feb;4(2):220–232. doi: 10.1101/gad.4.2.220. [DOI] [PubMed] [Google Scholar]
- Keller G., Snodgrass R. Life span of multipotential hematopoietic stem cells in vivo. J Exp Med. 1990 May 1;171(5):1407–1418. doi: 10.1084/jem.171.5.1407. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Li C. L., Johnson G. R. Rhodamine123 reveals heterogeneity within murine Lin-, Sca-1+ hemopoietic stem cells. J Exp Med. 1992 Jun 1;175(6):1443–1447. doi: 10.1084/jem.175.6.1443. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Moore M. A. Review: Stratton Lecture 1990. Clinical implications of positive and negative hematopoietic stem cell regulators. Blood. 1991 Jul 1;78(1):1–19. [PubMed] [Google Scholar]
- Okada S., Nakauchi H., Nagayoshi K., Nishikawa S., Nishikawa S., Miura Y., Suda T. Enrichment and characterization of murine hematopoietic stem cells that express c-kit molecule. Blood. 1991 Oct 1;78(7):1706–1712. [PubMed] [Google Scholar]
- Ploemacher R. E., Brons N. H. Cells with marrow and spleen repopulating ability and forming spleen colonies on day 16, 12, and 8 are sequentially ordered on the basis of increasing rhodamine 123 retention. J Cell Physiol. 1988 Sep;136(3):531–536. doi: 10.1002/jcp.1041360320. [DOI] [PubMed] [Google Scholar]
- Ploemacher R. E., Brons R. H. Separation of CFU-S from primitive cells responsible for reconstitution of the bone marrow hemopoietic stem cell compartment following irradiation: evidence for a pre-CFU-S cell. Exp Hematol. 1989 Mar;17(3):263–266. [PubMed] [Google Scholar]
- Ploemacher R. E., van der Sluijs J. P., Voerman J. S., Brons N. H. An in vitro limiting-dilution assay of long-term repopulating hematopoietic stem cells in the mouse. Blood. 1989 Dec;74(8):2755–2763. [PubMed] [Google Scholar]
- Smith L. G., Weissman I. L., Heimfeld S. Clonal analysis of hematopoietic stem-cell differentiation in vivo. Proc Natl Acad Sci U S A. 1991 Apr 1;88(7):2788–2792. doi: 10.1073/pnas.88.7.2788. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Spangrude G. J., Heimfeld S., Weissman I. L. Purification and characterization of mouse hematopoietic stem cells. Science. 1988 Jul 1;241(4861):58–62. doi: 10.1126/science.2898810. [DOI] [PubMed] [Google Scholar]
- Spangrude G. J., Johnson G. R. Resting and activated subsets of mouse multipotent hematopoietic stem cells. Proc Natl Acad Sci U S A. 1990 Oct;87(19):7433–7437. doi: 10.1073/pnas.87.19.7433. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Spangrude G. J., Smith L., Uchida N., Ikuta K., Heimfeld S., Friedman J., Weissman I. L. Mouse hematopoietic stem cells. Blood. 1991 Sep 15;78(6):1395–1402. [PubMed] [Google Scholar]
- Spooncer E., Lord B. I., Dexter T. M. Defective ability to self-renew in vitro of highly purified primitive haematopoietic cells. Nature. 1985 Jul 4;316(6023):62–64. doi: 10.1038/316062a0. [DOI] [PubMed] [Google Scholar]
- Uchida N., Weissman I. L. Searching for hematopoietic stem cells: evidence that Thy-1.1lo Lin- Sca-1+ cells are the only stem cells in C57BL/Ka-Thy-1.1 bone marrow. J Exp Med. 1992 Jan 1;175(1):175–184. doi: 10.1084/jem.175.1.175. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Udomsakdi C., Eaves C. J., Sutherland H. J., Lansdorp P. M. Separation of functionally distinct subpopulations of primitive human hematopoietic cells using rhodamine-123. Exp Hematol. 1991 Jun;19(5):338–342. [PubMed] [Google Scholar]
- Ulich T. R., del Castillo J., Yi E. S., Yin S., McNiece I., Yung Y. P., Zsebo K. M. Hematologic effects of stem cell factor in vivo and in vitro in rodents. Blood. 1991 Aug 1;78(3):645–650. [PubMed] [Google Scholar]
- Van Zant G., Chen J. J., Scott-Micus K. Developmental potential of hematopoietic stem cells determined using retrovirally marked allophenic marrow. Blood. 1991 Feb 15;77(4):756–763. [PubMed] [Google Scholar]
- Van Zant G., Eldridge P. W., Behringer R. R., Dewey M. J. Genetic control of hematopoietic kinetics revealed by analyses of allophenic mice and stem cell suicide. Cell. 1983 Dec;35(3 Pt 2):639–645. doi: 10.1016/0092-8674(83)90096-x. [DOI] [PubMed] [Google Scholar]
- Van Zant G., Holland B. P., Eldridge P. W., Chen J. J. Genotype-restricted growth and aging patterns in hematopoietic stem cell populations of allophenic mice. J Exp Med. 1990 May 1;171(5):1547–1565. doi: 10.1084/jem.171.5.1547. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Van Zant G., Scott-Micus K., Thompson B. P., Fleischman R. A., Perkins S. Stem cell quiescence/activation is reversible by serial transplantation and is independent of stromal cell genotype in mouse aggregation chimeras. Exp Hematol. 1992 May;20(4):470–475. [PubMed] [Google Scholar]
- Van Zant G. Studies of hematopoietic stem cells spared by 5-fluorouracil. J Exp Med. 1984 Mar 1;159(3):679–690. doi: 10.1084/jem.159.3.679. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Van Zant G., Thompson B. P., Chen J. J. Differentiation of chimeric bone marrow in vivo reveals genotype-restricted contributions to hematopoiesis. Exp Hematol. 1991 Oct;19(9):941–949. [PubMed] [Google Scholar]
- Visser J. W., de Vries P., Hogeweg-Platenburg M. G., Bayer J., Schoeters G., van den Heuvel R., Mulder D. H. Culture of hematopoietic stem cells purified from murine bone marrow. Semin Hematol. 1991 Apr;28(2):117–125. [PubMed] [Google Scholar]
- Visser J. W., de Vries P. Isolation of spleen-colony forming cells (CFU-s) using wheat germ agglutinin and rhodamine 123 labeling. Blood Cells. 1988;14(2-3):369–384. [PubMed] [Google Scholar]
- Worthington R. E., Bossie-Codreanu J., Van Zant G. Quantitation of erythroid differentiation in vitro using a sensitive colorimetric assay for hemoglobin. Exp Hematol. 1987 Jan;15(1):85–92. [PubMed] [Google Scholar]
- de Vries P., Brasel K. A., Eisenman J. R., Alpert A. R., Williams D. E. The effect of recombinant mast cell growth factor on purified murine hematopoietic stem cells. J Exp Med. 1991 May 1;173(5):1205–1211. doi: 10.1084/jem.173.5.1205. [DOI] [PMC free article] [PubMed] [Google Scholar]
- van der Sluijs J. P., de Jong J. P., Brons N. H., Ploemacher R. E. Marrow repopulating cells, but not CFU-S, establish long-term in vitro hemopoiesis on a marrow-derived stromal layer. Exp Hematol. 1990 Sep;18(8):893–896. [PubMed] [Google Scholar]